Forecast

The analysts' average price target is €3.29 (+78.80%). The median is €3.44 (+86.96%).

Buy	4
Hold	0
Sell	0

News Go to news feed

Research Solutions raises margins despite slight revenue decline in fiscal 2026

Research Solutions reported a 1.6% revenue decline in FY2026 to $48.3 million but increased its gross margin to 51.9%. Platform subscriptions rose about 10% to $20.8 million, ARR climbed 7.8% to $22.5 million, and AI-related ARR reached $0.8 million. Net profit doubled to $2.8 million, adjusted EBITDA increased, and the company holds $12.6 million in cash with no debt. Management expects AI and platform offerings to scale in 2027 and drive improved EBITDA and cash flow, but did not provide formal revenue guidance. » More on de.investing.com
Research Solutions to report results for quarter ended June 30, 2026, on September 9

Research Solutions will publish results for the quarter ended June 30, 2026 on September 9, 2026. Three analysts expect on average an EPS of $0.037 (prior year: $0.080) and revenue of $12.0 million (prior year: $12.4 million, -3.94%). For the fiscal year just ended, estimates average $0.130 per share and $48.2 million in revenue (prior year: $0.040 and $49.1 million). » More on finanzen.net

Financials

In the last quarter, RESEARCH SOLUTIONS INC had revenue of €10.59M and net profit of €583.17K

(EUR)	June 2026	YoY
Revenue	10.59M	0.31%
Gross profit	5.88M	15.07%
Net profit	583.17K	70.88%
EBITDA	784.08K	65.56%

Fundamentals

Metric	Value
Market capitalization	€61.5M
Number of shares	33.45M
52-week high/low	€3.54 - €1.72
Dividends	No
Beta	0.75
P/E ratio	31.38
PEG ratio	0.36
P/B ratio	3.25
P/S ratio	1.48

Company profile

Research Solutions, Inc. bietet über seine Tochtergesellschaften eine cloudbasierte Software-as-a-Service-Forschungsplattform an. Das Unternehmen ist auch am transaktionalen Verkauf von veröffentlichten wissenschaftlichen, technischen und medizinischen (STM) Inhalten beteiligt, die über die Transaktionsplattform verwaltet, beschafft und bereitgestellt werden. Seine Lösungen ermöglichen es Life-Science- und anderen forschungsintensiven Organisationen, ihre Forschungs- und Entwicklungsaktivitäten zu beschleunigen, indem sie Zugang zu STM-Artikeln erhalten und diese während des gesamten Lebenszyklus der Entwicklung von geistigem Eigentum verwalten. Das Unternehmen war früher als Derycz Scientific, Inc. bekannt und änderte im März 2013 seinen Namen in Research Solutions, Inc. Research Solutions, Inc. wurde im Jahr 2006 gegründet und hat seinen Sitz in Henderson, Nevada.

Name	RESEARCH SOLUTIONS INC
CEO	Roy W. Olivier
Headquarters	Henderson, nv USA
Website	researchsolutions.com
Sector	Industrials
Industry	Commercial Services & Supplies
IPO	11/15/2010
Employees	136